Linkedin Youtube
Launch Digital Edition

Webinars and Sponsored Roundtables — Register Now

Wednesday, September 23, 2026. 12 PM-1 PM ET
Roundtable presenters Dr. David Sacks MB, ChB, FRCPath, Chairman, Steering Committee National Glycohemoglobin Standardization Program (NGSP), and Priya Sivaraman, PhD, Senior Technical Product Manager, Tosoh Bioscience

Moderated by: Bob McGonnagle, Publisher, CAP TODAY

Register Now

Thursday, September 24, 2026 11 AM-12 PM CT
This session explores the evolving role of RAS in precision oncology, from the biology of RAS mutations to the expanding landscape of targeted therapies. Through expert presentations, real-world case discussions, and interactive audience polling, participants will examine best practices for RAS biomarker testing across solid tumors, including lung, colorectal, and pancreatic cancers. The session will highlight practical considerations for tissue and liquid biopsy, strategies to address testing gaps, and the importance of multidisciplinary collaboration to ensure timely identification of patients who may benefit from RAS-targeted therapies.

Webinar presenters David Braxton, MD, Chief of Molecular Pathology Services, Hoag Family Cancer Institute & Hoag Memorial Hospital Presbyterian, and Carlos Becerra, MD, Research Director for Medical Oncology, Margaret Given Larkin Endowed Chair for Developmental Cancer Therapeutics, Hoag Memorial Hospital Presbyterian

Moderated by: Bob McGonnagle, Publisher, CAP TODAY

Register Now

Wednesday, September 30, 2026. 1 PM-1:30 PM ET
Roundtable presenters John Longshore, PhD, Head of Scientific Affairs, Global Oncology Diagnostics, AstraZeneca, and Flora Berisha, MS, Executive Director, Global Head of Diagnostic Partnering and Development, Johnson & Johnson Innovative Medicine, and Mark D. Ewalt, MD, Associate Medical Director for Laboratory Operations, Diagnostic Molecular Pathology, Molecular Diagnostics Service, Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, and Isabel Preeshagul, DO, MBS, Thoracic Medical Oncologist, Memorial Sloan Kettering Cancer Center

Moderated by: Bob McGonnagle, Publisher, CAP TODAY

Register Now

Thursday, October 1, 2026 1 PM-2 PM ET
This presentation will explore the value of in-house CGP, offer insights into the benefits and drawbacks of incorporation, and provide information about important practical factors when considering in-house implementation of CGP.

Webinar presenter Allison M. Cushman-Vokoun, MD, PhD, FCAP, Medical Director, Molecular Diagnostics and Personalized Medicine Laboratory, Director, Division of Diagnostic Molecular Pathology and Human Genetics, Henry F. Krous Professor of Pathology, University of Nebraska Medical Center

Moderated by: Bob McGonnagle, Publisher, CAP TODAY

Register Now

Tuesday, October 20, 2026 11 AM-12 PM ET
Hear experts review the biological and clinical significance of the HER2 expression continuum in breast tissue, providing a clearer understanding of how these variations might impact diagnosis, and discuss the emerging importance of documenting HER2-low and HER2-ultralow categories using a validated IHC assay.

Webinar presenters Keith Wharton, MD, PhD, Global Medical Affairs Leader–Pathology, Roche Diagnostics Solutions, and Hannah Y. Wen, MD, PhD, Director, Breast Pathology Fellowship, Associate Team Leader, Breast Pathology Team, Attending Pathologist, Memorial Sloan Kettering Cancer Center

Moderated by: Bob McGonnagle, Publisher, CAP TODAY

Register Now

Subspecialties

Interactive Product Guides

Marketplace Directory

Alkaline-phosphatase polymer reagents, 4/13:86

Vector Laboratories now offers its ImmPress polymer detection reagents with alkaline phosphatase as the enzyme detection system. Available as anti-mouse and anti-rabbit ImmPress-AP alkaline-phosphatase polymer reagents, these products are designed to detect primary antibodies made in rabbit and mouse in immunohistochemical staining. They provide greater sensitivity than conventional alkaline-phosphatase antibody conjugates and other alkaline-phosphatase detection reagents.

Improved adenovirus detection for panel, 4/13:85

BioFire Diagnostics has received FDA clearance for its updated Film-Array respiratory panel. The purpose of the updated panel is to improve the detection of adenovirus. Studies performed to support the clearance of the modified panel demonstrated a 73 percent increase in the detection of adenovirus and a threefold improvement in the limit of detection when compared with the original panel.

Online digital pathology network, 4/13:85

PathCentral’s Pathology Network, www.pathcentralpro.net, is a comprehensive online information exchange and digital consultation forum. The network allows physicians to upload case files using digital images for pathologists to review and render critical consulting diagnoses on a global and a domestic real-time basis. The network seeks to connect pathologists by incorporating social media tools, making the forum ideal for pathologists to send and perform consultations, post information, share cases, ask questions, and expand professional relationships.

Whole-slide imaging application for AP QA, 4/13:85

QualityStar will present at the Cambridge Healthtech Institute’s Ninth Annual Biomarkers and Diagnostics World Congress a new application that uses whole-slide digital imaging (WSI) for anatomic pathology external peer review quality assurance. The presentation will review current quality assurance programs and the application of WSI as an approach to gain longitudinal benchmarking data for quality review.

RSV and hMPV assay, 4/13:85

Quidel has received FDA 510(k) clearance for its Molecular RSV and hMPV assay for the detection of respiratory syncytial virus and human metapneumovirus. The assay distinguishes between RSV and hMPV. The RSV and hMPV assay can be batched alongside other Quidel Molecular assays, such as the influenza A and B PCR assay, in the same multiwell panel for customized multiplexing capability.

Exome kits, software for next-gen sequencing, 4/13:84

Agilent Technologies’ HaloPlex exome kits and SureCall software complement the company’s Web-based SureDesign interface and custom HaloPlex gene panels to provide a complete, integrated workflow. The HaloPlex exome kit comprises about 2.5 million probes to provide comprehensive coverage of the coding regions of the human genome with minimal hands-on time. The kit requires only 200 ng of input DNA.

ACD, Hopkins reach cancer biomarkers deal, 4/13:84

Advanced Cell Diagnostics has entered into an agreement with Johns Hopkins University on behalf of the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, whereby ACD’s RNAscope technology will be used to validate novel biomarkers and drug targets for cancer immunotherapy.

Staining platform, 4/13:84

Dako’s Omnis solution, a new addition to the company’s immunohistochemistry portfolio, consists of hardware, software, and reagents. It automates IHC and ISH processes, allowing entire patient cases to be processed simultaneously. The solution offers continuous loading, batch loading, and overnight run options. Its state-of-the-art software allows slide processing and instrument maintenance to be traced to individual operators, greatly increasing quality control.

CRC detection test, 3/13:75

Epigenomics has submitted to the FDA the fourth and final module of its premarket approval for its blood-based Epi proColon test for the detection of colorectal cancer.

In vivo imaging system, 3/13:76

PerkinElmer’s Ivis Lumina series III benchtop platform is for oncology, infectious disease, and drug discovery and efficacy research. The system integrates bioluminescence and full spectral fluorescence in vivo imaging technologies, providing an expandable and sensitive benchtop imaging platform.

MARKETPLACE

TRENDING